HARP - Harpoon Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HARP is currently covered by 6 analysts with an average price target of $39.42. This is a potential upside of $16.41 (71.32%) from yesterday's end of day stock price of $23.01.

Harpoon Therapeutics's activity chart (see below) currently has 52 price targets and 53 ratings on display. The stock rating distribution of HARP is 66.67% BUY and 33.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.11% with an average time for these price targets to be met of 114 days.

Highest price target for HARP is $23, Lowest price target is $23, average price target is $39.42.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 26-Feb-2024. First documented stock forecast 05-Mar-2019.

Currently out of the existing stock ratings of HARP, 8 are a BUY (66.67%), 4 are a HOLD (33.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$23

$-0.01 (-0.04%)

$13

9 months 27 days ago
(26-Feb-2024)

4/9 (44.44%)

$0.07 (0.31%)

165

Hold

$23

$-0.01 (-0.04%)

$20

11 months 14 days ago
(09-Jan-2024)

4/5 (80%)

$0.64 (2.86%)

215

Hold

$23

$-0.01 (-0.04%)

$12

11 months 15 days ago
(08-Jan-2024)

3/4 (75%)

$0.64 (2.86%)

43

Buy

$12

$-11.01 (-47.85%)

1 years 10 days ago
(13-Dec-2023)

1/2 (50%)

$2.54 (26.85%)

9

Buy

$70

1 years 8 months 22 days ago
(31-Mar-2023)

0/5 (0%)

$50 (250.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HARP (Harpoon Therapeutics) average time for price targets to be met?

On average it took 114 days on average for the stock forecasts to be realized with a an average price target met ratio 44.11

Which analyst has the current highest performing score on HARP (Harpoon Therapeutics) with a proven track record?

YIGAL NOCHOMOVITZ

Which analyst has the most public recommendations on HARP (Harpoon Therapeutics)?

Yigal Nochomovitz works at CITI and has 24 price targets and 16 ratings on HARP

Which analyst is the currently most bullish on HARP (Harpoon Therapeutics)?

Zegbeh Jallah with highest potential upside - $116.99

Which analyst is the currently most reserved on HARP (Harpoon Therapeutics)?

Robert Driscoll with lowest potential downside - -$16.01

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?